SEC Form D private-offering filing

Altesa BioSciences, Inc.

Name: Altesa BioSciences, Inc. - new SEC Form D private-offering filing, College Park, GA
Published: 2026-02-23

A new SEC Form D private-offering notice from College Park, GA, a $74,999,986 filer-stated offering target in Biotech. The source filing is one click away.

Altesa BioSciences, Inc. site↗ Verified via SEC Form D

Clinical-stage pharmaceutical company developing vapendavir, an oral treatment for rhinovirus infections in patients with COPD and asthma.

Filed 2026-02-23Filed to raise $74,999,986First money in 2026-02-13Raised so far $74,999,986HQ (as filed) College Park, GASector Biotech ✓Stage (inferred) GrowthCall status Call-ready

Source linked the Form D on EDGAR↗Website verified altesabio.com↗Named in the filing 8 executives & directors

Open this row on the live feed →More new filings in Georgia →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.